Nonlinear dynamics of chemotherapeutic resistance
Abstract
We use a three-component replicator dynamical system with healthy cells, sensitive cells, and resistant cells, with a prisoners dilemma payoff matrix from evolutionary game theory to understand the phenomenon of competitive release, which is the main mechanism by which tumors develop chemotherapeutic resistance. By comparing the phase portraits of the system without therapy compared to continuous therapy above a certain threshold, we show that chemotherapeutic resistance develops if there are pre-exisiting resistance cells in the population. We examine the basin boundaries of attraction associated with the chemo-sensitive population and the chemo-resistant population for increasing values of chemo-concentrations and show their spiral intertwined structure. We also examine the fitness landscapes both with and without continuous therapy and show that with therapy, the average fitness as well as the fitness functions of each of the subpopulations initially increases, but eventually decreases monotonically as the resistant subpopulation saturates the tumor.
02 /Specification & Classification
Click any tag to browse matching papers- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- On the design of treatment schedules that avoid chemotherapeutic resistance
Y. Ma, P.K. Newton·bioRxiv·May 17, 2018
- The role of synergy and antagonism in designing multidrug adaptive chemotherapy schedules
- Competitive release in tumors
Yongqian Ma, Jeffrey West, Paul K. Newton·bioRxiv·Feb 10, 2018
- Stochastic competitive release and adaptive chemotherapy
J. Park, P. K. Newton·bioRxiv·Jun 17, 2022
- A Mathematical Framework for Comparison of Intermittent and Continuous Adaptive Chemotherapy Dosing in Cancer
Cordelia D. McGehee, Yoichiro Mori A·npj Systems Biology and ApplicationsPeer-reviewed·Nov 29, 2024
- Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies
J. A. Gallaher, P. M. Enriquez-Navas, … A. R. A. Anderson·bioRxiv·Sep 8, 2017